|
CSF Aβ/ptau Summary Statistics - Deming Y et al. (2017) |
|
|
|
|
CSF Summary Statistics- Cruchaga et al. (2013) |
|
|
|
|
CSF TREM2 Summary Statistics |
|
|
|
|
Dataset from Clinical and Pathological Studies in the Oldest Old (90+ Study) (via DSS) |
|
|
|
|
DNA Methylation in Alzheimer disease brains (via DSS) |
|
|
|
|
eGWAS Mayo |
|
|
|
|
Episodic Memory Trajectories (EMTs) of 13,037 elderly |
|
|
|
|
Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease |
|
|
|
|
ExomeChip - WashU |
|
|
236071 |
|
Expression Levels from AD Case-Control Study |
|
|
48803 |
|
Functional Annotation of genomic variants in studies of LOAD |
|
|
|
|
Genetic analyses of patients with CTE |
|
|
|
|
Genetic architecture of subcortical brain structures in 38,851 individuals summary statistics- Satizabal et al. 2019 |
|
|
|
|
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease (via DSS) |
|
|
|
|
Genetics Consortium for Late Onset of Alzheimers |
|
|
5616 |
|
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease |
|
|
|
|
Genome-wide summary statistics for cognitively defined late-onset Alzheimer’s disease subgroups |
|
|
|
|
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders (via DSS) |
|
|
|
|
GWAS of CLU, A potential endophenotype for Alzheimer's disease |
|
|
6015512 |
|
GWAS of CSF tau levels identifies risk variants for AD |
|
|
5815690 |
